Clinical trial
Does Anejaculation Reflect Better Clinical Outcomes in BPO Patients Receiving Silodosin?
NCT06989515 is registered in ClinicalTrials.gov with Marmara University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Does Anejaculation Reflect Better Clinical Outcomes in BPO Patients Receiving Silodosin?
- Lead sponsor
- Marmara University
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- June 15, 2025
- Completion date
- June 12, 2026
- Enrollment
- 100 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
anejaculation, benign prostate obstruction (bpo), ejaculatory dysfunction, lower urinary tract symptom, silodosin